Patents by Inventor Romi Barat Singh

Romi Barat Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285301
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 14, 2023
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • Patent number: 11690805
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: July 4, 2023
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Amit Kumar, Ravindra Agarwal, Pulak Kumar Metia, Kalaiselvan Ramaraju, Sumit Madan, Romi Barat Singh
  • Publication number: 20230172875
    Abstract: The present invention relates to extended release liquid compositions of guaifenesin. The extended release liquid compositions are in the form of suspensions which are ready-to-use or suspensions which are reconstituted from powder. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: January 30, 2023
    Publication date: June 8, 2023
    Inventors: Radhakrishna VANKAYALA, Balaram MONDAL, Sandeep Kumar VATS, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ashish KUMAR
  • Patent number: 11523996
    Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: December 13, 2022
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
  • Patent number: 11504345
    Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: November 22, 2022
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
  • Publication number: 20220105040
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: December 14, 2021
    Publication date: April 7, 2022
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • Publication number: 20200315994
    Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: June 23, 2020
    Publication date: October 8, 2020
    Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
  • Patent number: 10258583
    Abstract: The present invention relates to extended release liquid compositions of guanfacine. The extended release liquid compositions of the present invention are bioequivalent to marketed extended release tablet compositions of guanfacine. Said extended release liquid compositions provide substantially similar in-vitro dissolution release profile upon storage for at least seven days. Further, the extended release liquid compositions are stable. The extended release liquid compositions are in the form of ready-to-use liquid compositions or reconstituted liquid compositions. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: April 16, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Kalaiselvan Ramaraju, Balaram Mondal, Ashish Kumar, Suchitra Kaushik
  • Patent number: 10238803
    Abstract: The present invention relates to a dual-chamber pack with a first chamber comprising a container; and a second chamber comprising a reservoir, a biphasic connector, a plunger, and a plug with a breakable polymeric membrane. The container of the first chamber is prefilled with a pharmaceutically acceptable vehicle and the reservoir of the second chamber is prefilled with a solid composition of an active ingredient, wherein the solid composition of the active ingredient is mixed with the pharmaceutically acceptable vehicle to form a liquid pharmaceutical composition upon activation of the dual-chamber pack.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: March 26, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Ashish Kumar, Kalaiselvan Ramaraju, Romi Barat Singh, Bhupesh Kumar Mittal, Rahul Bhargava, Mohit Mittal
  • Publication number: 20190046468
    Abstract: The present invention relates to extended release liquid compositions of guaifenesin. The extended release liquid compositions are in the form of suspensions which are ready-to-use or suspensions which are reconstituted from powder. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: August 13, 2018
    Publication date: February 14, 2019
    Inventors: Radhakrishna VANKAYALA, Balaram MONDAL, Sandeep Kumar VATS, Kalaiselvan RAMARAJU, Romi Barat SINGH, Ashish KUMAR
  • Patent number: 10137094
    Abstract: The present invention relates to novel gastroretentive dosage systems, in particular, a floating capsule which releases the drug without any lag time and which remains buoyant for a sufficient period of time in the stomach. Further, the invention relates to the process of preparation thereof.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: November 27, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Varinder Kumar, Shavej Ahmad, Romi Barat Singh
  • Publication number: 20180318246
    Abstract: The present invention relates to pharmaceutical composition comprising dimethyl fumarate; an enzyme modulator or a permeation enhancer or both; and one or more pharmaceutically acceptable excipients. It further relates to a pulsatile release pharmaceutical composition comprising dimethyl fumarate and one or more pharmaceutically acceptable excipients. The compositions of the present invention are administered at a lower dose as compared to the recommended daily dose of Tecfidera®. Further, the compositions of the present invention are resistant to dose dumping in the presence of alcohol.
    Type: Application
    Filed: October 27, 2016
    Publication date: November 8, 2018
    Inventors: Chandrashekhar GARGOTE, Lalit GARG, Shrikant Vaijanathap HODGE, Subodh DESHMUKH, Romi Barat SINGH, Vikas BATRA, Som Akshay JAIN
  • Publication number: 20180221314
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 9, 2018
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Balaram MONDAL, Ashish KUMAR, Suchitra KAUSHIK
  • Publication number: 20180221290
    Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 9, 2018
    Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
  • Publication number: 20180193299
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Inventors: Rajesh RAO, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH
  • Patent number: 9999606
    Abstract: An oral pharmaceutical composition of isotretinoin and a carrier substrate, having isotretinoin in the form of gel, dispersion, solution or emulsion, which is absorbed onto the carrier substrate to form solid particles, powder, or granules. The oral pharmaceutical composition has enhanced bioavailability. A process is used for preparing the oral composition.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: June 19, 2018
    Assignee: Sun Pharmaceutical Industries Limited.
    Inventors: Rajesh Rao, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh
  • Publication number: 20180133399
    Abstract: The present invention relates to a dual-chamber pack with a first chamber comprising a container; and a second chamber comprising a reservoir, a biphasic connector, a plunger, and a plug with a breakable polymeric membrane. The container of the first chamber is prefilled with a pharmaceutically acceptable vehicle and the reservoir of the second chamber is prefilled with a solid composition of an active ingredient, wherein the solid composition of the active ingredient is mixed with the pharmaceutically acceptable vehicle to form a liquid pharmaceutical composition upon activation of the dual-chamber pack.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 17, 2018
    Inventors: Ashish KUMAR, Kalaiselvan RAMARAJU, Romi Barat SINGH, Bhupesh Kumar MITTAL, Rahul BHARGAVA, Mohit MITTAL
  • Patent number: 9962336
    Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: May 8, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
  • Patent number: 9962345
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: May 8, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Kalaiselvan Ramaraju, Balaram Mondal, Ashish Kumar, Suchitra Kaushik
  • Publication number: 20180104197
    Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: May 2, 2016
    Publication date: April 19, 2018
    Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN